Literature DB >> 17470557

Role for histone deacetylase 1 in human tumor cell proliferation.

Silvia Senese1, Katrin Zaragoza, Simone Minardi, Ivan Muradore, Simona Ronzoni, Alfonso Passafaro, Loris Bernard, Giulio F Draetta, Myriam Alcalay, Christian Seiser, Susanna Chiocca.   

Abstract

Posttranslational modifications of core histones are central to the regulation of gene expression. Histone deacetylases (HDACs) repress transcription by deacetylating histones, and class I HDACs have a crucial role in mouse, Xenopus laevis, zebra fish, and Caenorhabditis elegans development. The role of individual class I HDACs in tumor cell proliferation was investigated using RNA interference-mediated protein knockdown. We show here that in the absence of HDAC1 cells can arrest either at the G(1) phase of the cell cycle or at the G(2)/M transition, resulting in the loss of mitotic cells, cell growth inhibition, and an increase in the percentage of apoptotic cells. On the contrary, HDAC2 knockdown showed no effect on cell proliferation unless we concurrently knocked down HDAC1. Using gene expression profiling analysis, we found that inactivation of HDAC1 affected the transcription of specific target genes involved in proliferation and apoptosis. Furthermore, HDAC2 downregulation did not cause significant changes compared to control cells, while inactivation of HDAC1, HDAC1 plus HDAC2, or HDAC3 resulted in more distinct clusters. Loss of these HDACs might impair cell cycle progression by affecting not only the transcription of specific target genes but also other biological processes. Our data support the idea that a drug targeting specific HDACs could be highly beneficial in the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470557      PMCID: PMC1951481          DOI: 10.1128/MCB.00494-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

Review 1.  Histone deacetylases: silencers for hire.

Authors:  H H Ng; A Bird
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

Review 2.  Histone deacetylases, transcriptional control, and cancer.

Authors:  W D Cress; E Seto
Journal:  J Cell Physiol       Date:  2000-07       Impact factor: 6.384

3.  Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1.

Authors:  G W Humphrey; Y Wang; V R Russanova; T Hirai; J Qin; Y Nakatani; B H Howard
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

4.  Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres.

Authors:  K Ekwall; T Olsson; B M Turner; G Cranston; R C Allshire
Journal:  Cell       Date:  1997-12-26       Impact factor: 41.582

Review 5.  NuRD and SIN3 histone deacetylase complexes in development.

Authors:  J Ahringer
Journal:  Trends Genet       Date:  2000-08       Impact factor: 11.639

6.  Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.

Authors:  V M Richon; T W Sandhoff; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

7.  Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes.

Authors:  J Y Hsu; Z W Sun; X Li; M Reuben; K Tatchell; D K Bishop; J M Grushcow; C J Brame; J A Caldwell; D F Hunt; R Lin; M M Smith; C D Allis
Journal:  Cell       Date:  2000-08-04       Impact factor: 41.582

Review 8.  Discovery and development of SAHA as an anticancer agent.

Authors:  P A Marks
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

9.  Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases.

Authors:  A Taddei; C Maison; D Roche; G Almouzni
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

Review 10.  Novel roles for mammalian septins: from vesicle trafficking to oncogenesis.

Authors:  B Kartmann; D Roth
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  111 in total

Review 1.  Multiple roles of class I HDACs in proliferation, differentiation, and development.

Authors:  Nina Reichert; Mohamed-Amin Choukrallah; Patrick Matthias
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

Review 2.  The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men.

Authors:  Xiang-Jiao Yang; Edward Seto
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

3.  Heat-shock factor 1 controls genome-wide acetylation in heat-shocked cells.

Authors:  Sabrina Fritah; Edwige Col; Cyril Boyault; Jérôme Govin; Karin Sadoul; Susanna Chiocca; Elisabeth Christians; Saadi Khochbin; Caroline Jolly; Claire Vourc'h
Journal:  Mol Biol Cell       Date:  2009-09-30       Impact factor: 4.138

4.  A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.

Authors:  Theodoros N Teknos; J Grecula; A Agrawal; M O Old; E Ozer; R Carrau; S Kang; J Rocco; D Blakaj; V Diavolitsis; B Kumar; P Kumar; Q Pan; M Palettas; L Wei; R Baiocchi; P Savvides
Journal:  Invest New Drugs       Date:  2018-12-19       Impact factor: 3.850

5.  Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis.

Authors:  Jennifer Jurkin; Gordin Zupkovitz; Sabine Lagger; Reinhard Grausenburger; Astrid Hagelkruys; Lukas Kenner; Christian Seiser
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

6.  RBBP4 regulates histone deacetylation and bipolar spindle assembly during oocyte maturation in the mouse.

Authors:  Ahmed Z Balboula; Paula Stein; Richard M Schultz; Karen Schindler
Journal:  Biol Reprod       Date:  2015-03-18       Impact factor: 4.285

Review 7.  Histone deacetylases and cancer.

Authors:  Bruna Barneda-Zahonero; Maribel Parra
Journal:  Mol Oncol       Date:  2012-08-27       Impact factor: 6.603

8.  Specific activity of class II histone deacetylases in human breast cancer cells.

Authors:  Vanessa Duong; Caroline Bret; Lucia Altucci; Antonello Mai; Céline Duraffourd; Julie Loubersac; Pierre-Olivier Harmand; Sandrine Bonnet; Sergio Valente; Thierry Maudelonde; Vincent Cavailles; Nathalie Boulle
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

9.  Chfr is linked to tumour metastasis through the downregulation of HDAC1.

Authors:  Young Mi Oh; Young Eun Kwon; Joo Mi Kim; Sung Jun Bae; Bo Keun Lee; Soon Ji Yoo; Chin Ha Chung; Raymond J Deshaies; Jae Hong Seol
Journal:  Nat Cell Biol       Date:  2009-02-01       Impact factor: 28.824

10.  Functional characterization of the interactions between endosomal adaptor protein APPL1 and the NuRD co-repressor complex.

Authors:  Magdalena Banach-Orlowska; Iwona Pilecka; Anna Torun; Beata Pyrzynska; Marta Miaczynska
Journal:  Biochem J       Date:  2009-10-12       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.